Yongyin -. Li
600# Tianhe Road
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
A tirapazamine-assembled phototherapy agent for combined chemotherapy, photodynamic therapy, and photothermal therapy of hepatocellular carcinoma in mice.
Journal: Journal of materials chemistry. B
Published: April 22, 2026
Correspondence to editorial on "Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2CD16hi subset linked to hepatitis B virus outcomes".
Journal: Clinical and molecular hepatology
Published: January 20, 2026
Correspondence to letter to the editor on "Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes".
Journal: Clinical and molecular hepatology
Published: January 20, 2026
Polygonatum sibiricum polysaccharide delays age-related decline and preserves muscle integrity in Caenorhabditis elegans by modulating the daf-2/IIS pathway.
Journal: International journal of biological macromolecules
Published: January 20, 2026
PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.
Journal: Nature communications
Published: September 22, 2025
Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes.
Journal: Clinical and molecular hepatology
Published: August 18, 2025
Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK-STAT signaling pathway.
Journal: Cell death & disease
Published: June 12, 2025
IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection.
Journal: Journal of translational medicine
Published: June 02, 2025
Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7⁺ Subset Linked to Antiviral Potential in Chronic HBV Infection.
Journal: Journal of medical virology
Published: April 21, 2025
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells.
Journal: Investigational new drugs
Published: January 09, 2025
The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination.
Journal: Experimental & molecular medicine
Published: December 23, 2024
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure.
Journal: Emerging microbes & infections
Published: October 29, 2024
Last Updated: 09/26/2026